Exagen Inc (XGN)
1.42
+0.05
(+3.65%)
USD |
NASDAQ |
May 08, 11:23
Exagen Price: 1.42 for May 8, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 07, 2024 | 1.38 | 1.42 | 1.36 | 1.37 | 21055.00 |
| May 06, 2024 | 1.40 | 1.41 | 1.38 | 1.38 | 14859.00 |
| May 03, 2024 | 1.38 | 1.42 | 1.361 | 1.40 | 10429.00 |
| May 02, 2024 | 1.35 | 1.40 | 1.35 | 1.385 | 16679.00 |
| May 01, 2024 | 1.319 | 1.40 | 1.319 | 1.36 | 23747.00 |
| Apr 30, 2024 | 1.41 | 1.41 | 1.344 | 1.385 | 7726.00 |
| Apr 29, 2024 | 1.411 | 1.42 | 1.35 | 1.41 | 10122.00 |
| Apr 26, 2024 | 1.41 | 1.413 | 1.385 | 1.412 | 3601.00 |
| Apr 25, 2024 | 1.358 | 1.41 | 1.358 | 1.41 | 17178.00 |
| Apr 24, 2024 | 1.37 | 1.410 | 1.37 | 1.38 | 2617.00 |
| Apr 23, 2024 | 1.41 | 1.41 | 1.360 | 1.40 | 11155.00 |
| Apr 22, 2024 | 1.38 | 1.42 | 1.33 | 1.40 | 6118.00 |
| Apr 19, 2024 | 1.42 | 1.43 | 1.35 | 1.37 | 6591.00 |
| Apr 18, 2024 | 1.40 | 1.45 | 1.363 | 1.429 | 8542.00 |
| Apr 17, 2024 | 1.43 | 1.45 | 1.398 | 1.40 | 3840.00 |
| Apr 16, 2024 | 1.43 | 1.445 | 1.300 | 1.436 | 69432.00 |
| Apr 15, 2024 | 1.42 | 1.470 | 1.42 | 1.43 | 19419.00 |
| Apr 12, 2024 | 1.48 | 1.538 | 1.45 | 1.48 | 20718.00 |
| Apr 11, 2024 | 1.50 | 1.51 | 1.436 | 1.485 | 22245.00 |
| Apr 10, 2024 | 1.49 | 1.51 | 1.45 | 1.47 | 10589.00 |
| Apr 09, 2024 | 1.46 | 1.543 | 1.45 | 1.50 | 23157.00 |
| Apr 08, 2024 | 1.51 | 1.525 | 1.429 | 1.486 | 20751.00 |
| Apr 05, 2024 | 1.47 | 1.526 | 1.42 | 1.50 | 22183.00 |
| Apr 04, 2024 | 1.58 | 1.60 | 1.42 | 1.52 | 52228.00 |
| Apr 03, 2024 | 1.48 | 1.58 | 1.48 | 1.55 | 20347.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.36
Minimum
May 01 2024
28.48
Maximum
Dec 26 2019
9.349
Average
9.29
Median
Dec 13 2021
Price Benchmarks
| Fonar Corp | 16.90 |
| XWELL Inc | 1.75 |
| ProPhase Labs Inc | 5.25 |
| Applied DNA Sciences Inc | 3.77 |
| Veracyte Inc | 20.06 |
Price Related Metrics
| PS Ratio | 0.4777 |
| Price to Book Value | 1.078 |
| Earnings Yield | -94.37% |
| Market Cap | 24.47M |